Exploring how social factors influence pain expression and assessment
Official title: Sociocultural & Biobehavioral Influences on Pain Expression and Assessment
Run by National Institutes of Health Clinical Center (CC) · NCT03258580 · Data updated 2026-11-12
This study is trying to see how social factors affect how people show and report pain, especially in disadvantaged groups, to find better ways to assess and treat pain fairly.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 700 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | May 9, 2018 |
| Main results expected | May 17, 2027 |
| Study ends | May 30, 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT03258580 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 18 to 60 who are fluent in English and can provide informed consent.
✕Probably not a fit
Patients with major medical conditions, mood disorders, or those who do not reside in the United States may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the behavioral, psychophysiological, and social processes that contribute to biases and disparities in pain experiences and treatment. It focuses on how interpersonal dynamics, such as pain expression and assessment, may differ across various demographics, particularly among disadvantaged populations. The research employs interventions like thermal and electric stimulation, as well as pain assessment feedback, to evaluate these influences. By understanding these factors, the study aims to develop interventions that improve pain assessment accuracy and reduce biases in treatment.
Why it matters
Potential benefit: If successful, this research could lead to more equitable pain assessment and treatment for diverse populations.
How similar studies have gone: Other studies have indicated that addressing social factors in pain assessment can lead to improved outcomes, suggesting this approach has potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: All Sub-Studies: * Healthy * Between 18 and 60 years old * Fluent in English * Able to provide written informed consent EXCLUSION CRITERIA: All Sub-Studies: * Unable to comply with study procedures * Has a major-medical condition or medical history that in a clinician's assessment could affect ability to comply with study procedures, including neurological conditions (including stroke, blindness or deafness, or a history of brain damage) * Has a current mood disorder, anxiety disorder, or substance use disorder, or has a history of psychosis, hospitalization for a mental health condition, or recurrent psychiatric episodes. * NIH staff member who is a subordinate/relative/co-worker of any investigator on the protocol * Prior completion of a different sub-study within this protocol. * Is born outside of the states or territories of the United States of America * Does not currently reside in a state or territory of the United States of America Sub-study 1: * Has a major-medical condition or medical history that in a clinician's assessment could affect heat sensitivity or pain thresholds. This may include cardiovascular, autonomic, or neurological conditions or a chronic systemic disease (e.g., diabetes) * Has a medical condition that in a clinician's assessment might affect somatosensation (e.g., Raynaud's disease, peripheral neuropathy, or circulatory disorder) * Has a current chronic pain condition or has had chronic pain in the past (painful condition lasting more than six months) * Has a dermatological condition affecting the testing region, such as scars, burns, or recent tattoos that might influence cutaneous sensibility * Regular use of prescription medication that has a significant effect on pain or heat perception. Excluded medications include central-acting agents such as opiates (morphine, tramadol), antidepressants (amitriptyline, duloxetine, milnacipran), anticonvulsants (gabapentin, pregabalin), anxiolytics (barbituates, benzodiazepines), hypnotics (zolpidem, sodium oxybate), antipsychotics (valproate, lithium, olanzapine), antimigraine agents (sumatriptan, ergotamine), and muscle relaxants (cyclobenzaprine, carisoprodol). Use of analgesic medications, such as non-steroidal anti-inflammatories, salicylates, and acetaminophen, taken on an "as needed" basis is acceptable as long as the last dose was not taken was within 5 half-lives of testing. * Is left handed Sub-study 4, FMRI participants: * Has a current chronic pain condition or has had chronic pain in the past (painful condition lasting more than six months) * Is left-handed * Any FMRI contraindications, including: * Ferromagnetic metal in the cranial cavity or eye, e.g. aneurysm clip, implanted neural stimulator, cochlear implant, ocular foreign body. * Implanted cardiac pacemaker or auto-defibrillator. * Insulin pump. * Irremovable body piercing. * Pregnant women (based on urine test completed within 24 hours prior to scan). * Those with an abnormality on a structural MRI that has functional consequences based on clinician assessment.
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: Lauren Y Atlas, Ph.D. — National Center for Complementary and Integrative Health (NCCIH)
- Study coordinator: Adebisi O Ayodele, C.R.N.P.
- Email: bisi.ayodele@nih.gov
- Phone: (301) 827-0415
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using deep learning and Raman spectroscopy for early cancer diagnosis
This study is trying to see if a new deep learning tool using blood samples can help spot early signs of different types of cancer, like colorectal and gastric cancers, in both healthy people and those already diagnosed.
-
Using brain stimulation to improve learning and decision-making
This study is testing if a type of brain stimulation can help healthy adults learn better and make smarter decisions.
-
Using MRI to guide brain stimulation for memory improvement
This study is testing a new way to boost memory by using MRI scans to guide brain stimulation for people with mild cognitive impairment and healthy individuals.
-
Understanding how light affects sleep and body clocks based on age and sex
This study is testing how different ages and sexes respond to light and how that affects sleep and body clocks in healthy people.
-
Developing and validating tasks for learning and decision-making
This study is testing new tasks to see how people with substance use disorders learn and make decisions, using activities that may involve brain scans to understand their responses better.
-
Collection of blood and urine samples from healthy individuals for future research
This study is collecting blood and urine samples from healthy adults to help with future medical research.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.